Transanal endoscopic microsurgery resection of rectal tumors: outcomes and recommendations.

PURPOSE: Transanal endoscopic microsurgery provides a minimally invasive alternative to radical surgery for excision of benign and malignant rectal tumors. The purpose of this study was to review our experience with transanal endoscopic microsurgery to clarify its role in the treatment of different types of rectal pathology. METHODS: A prospective database documented all patients undergoing transanal endoscopic microsurgery from October 1996 through June 2008. We analyzed patient and operative factors, complications, and tumor recurrence. For recurrence analysis, we excluded patients with fewer than 6 months of follow-up, previous excisions, known metastases at initial presentation, and those who underwent immediate radical resection following transanal endoscopic microsurgery. RESULTS: Two hundred sixty-nine patients underwent transanal endoscopic microsurgery for benign (n = 158) and malignant (n = 111) tumors. Procedure-related complications (21%) included urinary retention (10.8%), fecal incontinence (4.1%), fever (3.8%), suture line dehiscence (1.5%), and bleeding (1.5%). Local recurrence rates for 121 benign and 83 malignant tumors were 5% for adenomas, 9.8% for T1 adenocarcinoma, 23.5% for T2 adenocarcinoma, 100% for T3 adenocarcinoma, and 0% for carcinoid tumors. All 6 (100%) recurrent adenomas were retreated with endoscopic techniques, and 8 of 17 (47%) recurrent adenocarcinomas underwent salvage procedures with curative intent. CONCLUSIONS: Transanal endoscopic microsurgery is a safe and effective method for excision of benign and malignant rectal tumors. Transanal endoscopic microsurgery can be offered for (1) curative resection of benign tumors, carcinoid tumors, and select T1 adenocarcinomas, (2) histopathologic staging in indeterminate cases, and (3) palliative resection in patients medically unfit or unwilling to undergo radical resection.

Loi et Jugement dernier dans le Nouveau Testament

(Résumé de l'ouvrage) Bible et droit : la confrontation est inédite. Au fil des cinq études, l'ouvrage explore le droit dans la Bible et la Bible dans le droit. Il étudie d'abord le droit d'Israël dans l'Ancien Testament, l'institution du jubilé, la loi et le jugement dernier dans le Nouveau Testament. Il s'interroge ensuite sur la présence de la Bible dans le droit : le droit occidental, et en particulier la législation en bioéthique, et le droit interne à l'Église ou droit canonique. Du droit biblique à l'engagement pour le droit d'aujourd'hui, un livre qui fait le pont.

Putative adverse outcome pathways relevant to neurotoxicity.

The Adverse Outcome Pathway (AOP) framework provides a template that facilitates understanding of complex biological systems and the pathways of toxicity that result in adverse outcomes (AOs). The AOP starts with an molecular initiating event (MIE) in which a chemical interacts with a biological target(s), followed by a sequential series of KEs, which are cellular, anatomical, and/or functional changes in biological processes, that ultimately result in an AO manifest in individual organisms and populations. It has been developed as a tool for a knowledge-based safety assessment that relies on understanding mechanisms of toxicity, rather than simply observing its adverse outcome. A large number of cellular and molecular processes are known to be crucial to proper development and function of the central (CNS) and peripheral nervous systems (PNS). However, there are relatively few examples of well-documented pathways that include causally linked MIEs and KEs that result in adverse outcomes in the CNS or PNS. As a first step in applying the AOP framework to adverse health outcomes associated with exposure to exogenous neurotoxic substances, the EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) organized a workshop (March 2013, Ispra, Italy) to identify potential AOPs relevant to neurotoxic and developmental neurotoxic outcomes. Although the AOPs outlined during the workshop are not fully described, they could serve as a basis for further, more detailed AOP development and evaluation that could be useful to support human health risk assessment in a variety of ways.

Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy.

BACKGROUND: The single nucleotide polymorphism (SNP) rs2542151 within the gene locus region encoding protein tyrosine phosphatase non-receptor type 2 (PTPN2) has been associated with Crohn's disease (CD), ulcerative colitis (UC), type-I diabetes, and rheumatoid arthritis. We have previously shown that PTPN2 regulates mitogen-activated protein kinase (MAPK) signaling and cytokine secretion in human THP-1 monocytes and intestinal epithelial cells (IEC). Here, we studied whether intronic PTPN2 SNP rs1893217 regulates immune responses to the nucleotide-oligomerization domain 2 (NOD2) ligand, muramyl-dipeptide (MDP). MATERIALS AND METHODS: Genomic DNA samples from 343 CD and 663 non-IBD control patients (male and female) from a combined German, Swiss, and Polish cohort were genotyped for the presence of the PTPN2 SNPs, rs2542151, and rs1893217. PTPN2-variant rs1893217 was introduced into T(84) IEC or THP-1 cells using a lentiviral vector. RESULTS: We identified a novel association between the genetic variant, rs1893217, located in intron 7 of the PTPN2 gene and CD. Human THP-1 monocytes carrying this variant revealed increased MAPK activation as well as elevated mRNA expression of T-bet transcription factor and secretion of interferon-γ in response to the bacterial wall component, MDP. In contrast, secretion of interleukin-8 and tumor necrosis factor were reduced. In both, T(84) IEC and THP-1 monocytes, autophagosome formation was impaired. CONCLUSIONS: We identified a novel CD-associated PTPN2 variant that modulates innate immune responses to bacterial antigens. These findings not only provide key insights into the effects of a functional mutation on a clinically relevant gene, but also reveal how such a mutation could contribute to the onset of disease.

Exposition des travailleurs agricoles aux pesticides : revue systématique de la littérature scientifique disponible sur les expositions aux pesticides des travailleurs agricoles en France

Le présent rapport rend compte d'une partie du travail déjà réalisé sur l'inventaire des données disponibles dans la littérature scientifique sur l'exposition des travailleurs agricoles aux pesticides en France. La possibilité de tirer parti de la littérature produite sur d'autres pays que la France est également explorée dans deux études de cas (réentrée en arboriculture et insecticides en élevages ovins). Les résultats seront exposés par ailleurs car le recueil et l'analyse de données produites par ces études sur les situations d'exposition des personnes travaillant en milieu agricole dans des pays étrangers posent des problèmes méthodologiques spécifiques si on veut pouvoir en tirer des enseignements pour la France. En matière de revue de la littérature scientifique, l'idéal de l'exhaustivité est généralement impossible à atteindre pour des raisons qui tiennent à la croissance exponentielle du nombre de publications scientifiques, à la pluralité des langues de publication, à la fragmentation et à l'accessibilité limitée des bases documentaires ... Nous pensons avoir recueilli tous les documents accessibles, mais peut-être certains nous ont-il échappé. C'est pourquoi le présent rapport est à la fois un exposé de résultats et un appel à contributions complémentaires. Il explicite les détails de la démarche adoptée (critères de sélection des articles, traçabilité des étapes de l'analyse ...) sous une forme qui permet à chacun d'avoir prise sur les résultats mais aussi de proposer des compléments au recensement réalisé. Il vise à être la première brique d'une base de connaissances partagée qui permette de capitaliser les données disponibles et qui puisse être mise à jour régulièrement.